Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2003
12/17/2003CN1462195A Pharmaceutical compositions comprising dendritic cells for immunotherapy of automimmune disease and treatment methods using the same
12/17/2003CN1462192A Blood cell production via activation of hemeglobin scavenger receptor
12/17/2003CN1462191A Treatment of ocute coronary syndrome with GLP-1
12/17/2003CN1462190A The use of copolymer 1 and related peptides and polypeptides and T cell treated therewith for neuroprotective therapy
12/17/2003CN1462189A Midicial herbal compound for prevention and treatment of diabetes
12/17/2003CN1131309C IL-6 mutein
12/17/2003CN1131235C 11'beta-halogen-7alpha-substd estratrienes, Preparation of Pharmaceutical preparation containing 11'beta'-halogen-7alpha-substd estratrienes
12/17/2003CN1131230C Tricyclic delta 3-piperidines as alpha 2-antagonists
12/17/2003CN1131228C Benzo (5,6) cyclohepta (1,2-6) pyridine derivs. for inhibition of farnesy-protein transferase
12/17/2003CN1131226C Novel 1,2-amylic cycle disulfide, its preparation method and medicinal compositions containing same
12/17/2003CN1131224C Luteolin and method for preparationg luteolin derivatives
12/17/2003CN1131222C Benzamide derivs and their use as APOB-100 secretion inhibitors
12/17/2003CN1131215C Cyclic and heterocyclic n-substituted 'alpha'-iminoh-ydroxamic acid and carboxylic acids
12/17/2003CN1131214C Tetrahy droquimoline derivatives as EAA antagonists
12/17/2003CN1131069C Anti-disease silk increasing agent for silk worm
12/17/2003CN1131059C Life-prolonging tea
12/17/2003CN1131031C Use of 4-phenyl-3,6-dihydro-2H-pyridyl derivatives for NMDA receptor subtype blockers
12/16/2003US6664395 Benzotriazole compoundsn are the potent inhibitors of MAP kinases, preferably p38 kinase. They are useful for treating inflammation, osteoarthritis, rheumatoid arthritis, cancer, reperfusion, ischemia
12/16/2003US6664394 As inactivator of antigen- specific T cells is useful in the prophylaxis or therapy of autoimmune diseases, disorders involving an autoimmune component or neoplastic diseases
12/16/2003US6664393 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
12/16/2003US6664370 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
12/16/2003US6664274 Piperidine derivatives as serotonine reuptake inhibitors
12/16/2003US6664273 Having at least cyanobenzyl and amidobenzyl substituents; obesity, metabolic disorders, eating disorders such as hyperphagia and diabetes
12/16/2003US6664272 Such as 1,5-Bis-(2, 4-difluorophenyl)penta-1,4-diene-3 -one; administering to inhibit tissue factor and vascular endothelial growth factor (VEGF) production in cancerous tissue
12/16/2003US6664269 Isoquinolinone derivatives
12/16/2003US6664264 Thioether substituted imidazoquinolines
12/16/2003US6664258 Spirocyclic dopamine receptor subtype ligands
12/16/2003US6664255 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
12/16/2003US6664247 Pyrazole compounds useful as protein kinase inhibitors
12/16/2003US6664236 Mixtures of glucosides obtained by solvent extraction from plants, comprising barlerin, acetyl barlerin, shanshizide methyl esters and adjuvants, used for detoxification, immunomodulation and as anxiolytic agents
12/16/2003US6664229 Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72
12/16/2003US6664227 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
12/16/2003US6664105 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
12/16/2003US6664068 Antibodies, antiapoptotic agents
12/16/2003US6664040 Complexing to polypeptides; antiproliferation agent
12/16/2003US6663900 Processed in a fluidized bed coating machine where a protective coating of a sugar or polyhydric alcohol, starch
12/16/2003US6663878 Anti-inflammatory bioactive glass particulates
12/16/2003US6663876 Methods and compositions for treating ectoparasite infestation
12/16/2003CA2195125C Difluorostatone antiviral agents
12/16/2003CA2093125C Angiotensin ii antagonists
12/11/2003WO2003102576A1 POLYUBIQUITINATION OF RB CATALYZED BY Mdm2
12/11/2003WO2003102237A1 Treatment with cytokines
12/11/2003WO2003102206A2 Sgk and nedd used as diagnostic and therapeutic targets
12/11/2003WO2003102197A1 Transgenic plants with controlled distribution of a trait to progeny
12/11/2003WO2003102188A1 Mutated androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof
12/11/2003WO2003102187A1 Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence
12/11/2003WO2003102183A1 Pramyxovirus vectors encoding antibody and utilization thereof
12/11/2003WO2003102180A1 NOVEL PEPTIDES HAVING cAMP PRODUCING ACTIVITY
12/11/2003WO2003102151A2 Modulating cell differentiation and treating myeloprolifertive disorders with jnk/mkk inhibitors
12/11/2003WO2003102140A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis
12/11/2003WO2003102014A2 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
12/11/2003WO2003101996A2 Esters in position 20 of camptothecins
12/11/2003WO2003101995A2 Camptothecins with a modified lactone ring
12/11/2003WO2003101989A1 Inhibitors of jak and cdk2 protein kinases
12/11/2003WO2003101988A2 Compounds and compositions for the treatment of diabetes and diabetes-related disorders
12/11/2003WO2003101987A1 3-substituted quinuclidines and their use
12/11/2003WO2003101984A1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same
12/11/2003WO2003101983A1 Tetrahydropyran derivative
12/11/2003WO2003101981A1 Novel substituted indoles
12/11/2003WO2003101980A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors
12/11/2003WO2003101978A1 Phenyl-thiophene type vitamin d receptor modulators
12/11/2003WO2003101970A1 Imidazolium cxcr3 inhibitors
12/11/2003WO2003101968A1 Pyrazole compound and medicinal composition containing the same
12/11/2003WO2003101964A1 Piperidine derivative, process for producing the same, and use
12/11/2003WO2003101961A1 Novel substituted indoles
12/11/2003WO2003101959A1 Pyrrole compounds for the treatment of prostaglandin mediated diseases
12/11/2003WO2003101958A2 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors
12/11/2003WO2003101957A1 New salts
12/11/2003WO2003101950A2 Methods for enhancing motor performance and/or endurance
12/11/2003WO2003101932A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/11/2003WO2003101927A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
12/11/2003WO2003101493A1 Intravenous composition, process for producing the same and preparation thereof
12/11/2003WO2003101490A1 Drug composition containing calcium channel antagonist
12/11/2003WO2003101489A1 Medicinal composition for treatment for digestive tract disease
12/11/2003WO2003101472A1 Dioxin elimination promoter
12/11/2003WO2003101466A1 Rubrofusarin glycoside-containing composition
12/11/2003WO2003101464A1 Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food
12/11/2003WO2003101455A2 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use
12/11/2003WO2003101453A1 Triple monoamine reuptake inhibitors for the treatment of chronic pain
12/11/2003WO2003101451A1 Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue
12/11/2003WO2003101450A1 N- ((3-oxo2, 3-dihydro-1h-isoindol-1-yl) acetyl) guanidine derivatives as nhe-1 inhibitors for the treatment of infarction and angina pectoris
12/11/2003WO2003101441A1 Monotherapy for the treatment of amyotrophic lateral sclerosis with cyclooxygenase-2 (cox 2) inhibitor(s)
12/11/2003WO2003101432A1 Combination immediate release controlled release levodopa/carbidopa dosage forms
12/11/2003WO2003101426A2 Simple and multiple emulsions for decontamination of an organism or surfaces
12/11/2003WO2003101424A1 Modified release pharmaceutical formulation
12/11/2003WO2003101395A2 Formulations for amylin agonist peptides
12/11/2003WO2003101386A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis
12/11/2003WO2003101382A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor
12/11/2003WO2003101380A2 Amyotrophic lateral sclerosis treatment with cyclooxygenase-2 inhibitors
12/11/2003WO2003101379A2 Pyranoindazoles and their use for the treatment of glaucoma
12/11/2003WO2003101376A2 Topical use of at least one double-stranded rna oligonucleotide (ds rna)
12/11/2003WO2003101375A2 Immunostimulatory oligonucleotides and uses thereof
12/11/2003WO2003101188A1 Chronic stress-related disease model animal and method of constructing the same
12/11/2003WO2003087090A3 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
12/11/2003WO2003080630A3 Phosphate transport inhibitors
12/11/2003WO2003080566A3 Hif hydroxylase inhibitors
12/11/2003WO2003064463A3 Pluripotency determining factors and uses thereof
12/11/2003WO2003057666A3 Inhibitors of dipeptidyl peptidase iv
12/11/2003WO2003057202A8 Use of a gsk-3beta inhibitor in the manufacture of a medicament for increasing bone formation
12/11/2003WO2003051289A3 Solubilized topoisomerase poison agents
1 ... 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 ... 1564